Skip to main content
    P

    PACS Group, Inc. (PACS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $49.04
    +0.72 (+1.49%)

    Market Cap: $7.67B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    PACS Group, Inc. (PACS) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    PACS Group (PACS) trades at 21.0x trailing earnings and 1.4x sales. Its forward P/E is 18.3x. The median P/E across 12 similar companies is 24.2x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 14.8% higher over the next year. Its free cash flow yield is 0.1%.

    MultipleValue
    P/E (trailing)21.0x
    Forward P/E18.3x
    Price to sales1.4x
    Price to book6.4x
    EV/EBITDA15.8x
    Price to FCF941.4x
    EV/FCF960.4x
    PEG1.2
    FCF yield0.1%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PACS

    What is PACS's forward P/E ratio?

    PACS Group has a forward P/E ratio of 18.3x.

    Is PACS stock overvalued?

    GNG's valuation label for PACS is Fairly valued. Its P/E of 21.0x compares with a median of 24.2x across 12 similar companies.

    What is PACS's price to sales ratio?

    PACS Group has a price to sales ratio of 1.4x.

    What is PACS's PEG ratio?

    PACS Group has a PEG ratio of 1.2.